Decode: AI for Life Sciences & Healthcare
Temporada 1
From VHS Tapes to AI Agents: Making Pharma Insights Irresistible Again
por ZoomRx
In this episode of Decode - AI in Life Sciences and Healthcare, host Sriram Subramanian, Co-Founder and Co-CEO of ZoomRx, sits down with John Shortell, Senior Director, Global Analytics & Insights at Revolution Medicines, to explore what AI really means for the pharma insights function and the leaders who run it. John brings 30+ years of experience in pharmaceutical market research, having led global insights teams through every major technology wave from big data to digital transformation. At the time of recording, he was Executive Director of Data Science & Advanced Analytics, Global Oncology at Bayer. His career has spanned Canada, the US, and Germany, and he shares a practitioner's perspective on where AI will genuinely elevate the insights function, and what it takes to lead teams through that change. Notable Quote: "I don't believe AI is going to eliminate insights teams. I think it's going to elevate them. And I think embracing AI does truly have the potential to make insights matter again." A must-listen for insights and analytics leaders, market research directors, and commercial decision-makers navigating AI adoption in pharma.
In this inaugural episode of Decode - AI in Lifesciences and Healthcare, host Sriram Subramanian, Co-Founder and Co-CEO of ZoomRx sits down with Jeremy Sauer, VP of Strategy at Callio Therapeutics, to cut through the AI hype and identify where artificial intelligence will genuinely move the needle in life sciences. Jeremy brings a uniquely broad perspective, having worked across management consulting, early-stage biotech, and large pharma. Drawing on his experience at Pfizer, Seagen, and now Callio, he shares candid insights on the "jagged frontier" of AI capabilities - what's possible today versus what still needs to be built. Key Topics Discussed: The Reality Check: Why AI is fundamentally different from previous tech waves, and why pharma's enthusiasm this time feels different Low-Hanging Fruit: How operational applications like clinical protocol writing and competitive intelligence are already delivering value The Discovery Dream: Why the "AI-designed drug" remains years away, and what data challenges stand in the way Clinical Trials: Where AI can dramatically reduce the 1/3 of trial sites that never enroll a single patient Leading Through Transformation: Managing teams through existential uncertainty and the uncomfortable truth about automation The Organizational Challenge: Why decentralized experimentation beats appointing a Chief AI Officer (for now) The Ultimate Bottleneck: How poor preclinical models, not discovery, may be pharma's biggest AI opportunity Notable Quote: "The only way to win is to play the game. To ignore it and say 'I can do it faster on my own' is going to be the losing bet." A must-listen for market research directors, clinical development leaders, and strategic decision-makers navigating the AI revolution in life sciences.